Time-Restricted Eating for Alzheimer's Disease
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether a time-restricted eating schedule (eating all meals within a 10-hour window each day) can improve memory and thinking in people with early Alzheimer's disease or mild cognitive impairment. Healthy partners of people with memory problems can also join as a comparison group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years old or older.
- You have mild memory problems or Alzheimer's disease (with a positive test for amyloid protein), or you are a healthy partner living with someone who has memory problems.
- You currently eat over a period of more than 12 hours each day (for example, from 7am to 8pm or longer).
- You are willing to try eating only during a 10-hour window and fasting for 14 hours each night.
- You do not have diabetes, do not use insulin, and are not taking any weight-loss or appetite-suppressing medicines like Wegovy or Ozempic.
- You have not started a new memory medicine (or changed dose) in the last 3 months, and you have no history of eating disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a structured “time-restricted eating” schedule is practical and safe for women with mild cognitive impairment (mild memory/thinking changes). You may be able to join if your routine and health conditions fit the study rules, and they will focus on eating timing and daily patterns.
This study tests whether a combination of time-restricted eating and mindfulness can help protect brain health in people with early memory concerns. It lasts 9 months and includes regular guidance and support.
This trial studies a non-medication (non-drug) program to improve memory and daily thinking in people with mild cognitive impairment or mild Alzheimer’s disease. It may help by supporting brain function and monitoring symptoms over time.
This study tests a sequence of treatments to see if they can help people with Alzheimer's disease or mild cognitive impairment. It aims to slow down memory decline and improve daily function.
This study looks at how diet-related and blood “stress” markers relate to how thinking and memory decline over time in people with Alzheimer’s. It may help researchers find useful biomarkers to better track progression and guide future care.
This trial tests whether changing caffeine intake can improve thinking and brain function in people with Alzheimer’s disease. You may qualify if you can follow a low-caffeine diet and have stable Alzheimer’s treatment and sleep/heart conditions.
Hear when a new Mild Cognitive Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.